• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » FDA launches medtech ‘voluntary compliance’ pilot | MassDevice.com On Call

FDA launches medtech ‘voluntary compliance’ pilot | MassDevice.com On Call

December 13, 2013 By Arezu Sarvestani

MassDevice.com On Call

MASSDEVICE ON CALL — Federal healthcare regulators are inviting certain medical device companies to self-report regulatory violations, promising that companies that cooperate will get to avoid FDA inspections.

Participants must retain an outside consultant to assess manufacturing and quality assurance programs, and they must demonstrate that they have methods and resources to "define problems, analyze root causes, create appropriate corrective actions, and verify that the actions taken were effective."

Only 3-5 manufacturers will be selected to participate in the FDA’s Voluntary Compliance Improvement Program, the agency said. Participants will not be subject to routine surveillance inspections for the duration of the program and the 2 years afterward.

"The FDA supports using new approaches to help companies come into compliance," according to the FDA memo. "These approaches benefit industry and may decrease the number of inspections that the FDA performs or permit the agency to focus on manufacturers with serious and ongoing problems."

 Medtronic’s tiny pacemaker sets world record

The World Record Academy granted medtech titan Medtronic (NYSE:MDT) a world record for its tiny pacemaker, implanted via catheter and about the size of a vitamin, which just this month was implanted in the 1st human patient.
Read more

 GE to pay $34M over deceptive healthcare credit card practices
GE Healthcare (NYSE:GE) was ordered to pay $34.1 million to repay patients who were allegedly scammed into signing up for the company’s healthcare credit cards at doctors’ and dentists’ offices.
Read more

 Short-term "doc fixes" don’t curry much favor with docs
Physicians hoping to do away with the annual scramble to delay severe cuts to Medicare reimbursement rates didn’t see much consolation from another temporary delay proposed by the latest budget deal.  
Read more

 Deep brain stimulation may increase fall risk in Parkinson’s patients, researchers say
Researchers report from a study of more than 1,100 patients  
Read more

Filed Under: Food & Drug Administration (FDA), News Well, Regulatory/Compliance Tagged With: On Call

More recent news

  • BD files patent infringement lawsuit against Baxter over infusion pump tech
  • Tandem Diabetes Care subsidiary earns new FDA clearance for insulin infusion set
  • Apreo Health emerges from stealth with positive data for lung scaffold
  • Tivic adds new vagus nerve stim patent
  • Study backs Teleflex stapler for reducing post-op GERD rates

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy